AI
PBH icon

Axiom Investors’s Prestige Consumer Healthcare PBH Stock Holding History

Axiom Investors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,120
Closed -$1.13M – 137
2022
Q4 		$1.13M Sell
18,120
-17,305
-49% -$992K 0.02% 114
2022
Q3 		$1.76M Sell
35,425
-47,745
-57% -$2.64M 0.04% 110
2022
Q2 		$4.89M Buy
+83,170
New +$4.59M 0.15% 78
2017
Q1 		– Sell
-63,508
Closed -$3.31M – 158
2016
Q4 		$3.31M Buy
63,508
+34,162
+116% +$1.65M 0.09% 98
2016
Q3 		$1.42M Sell
29,346
-33,006
-53% -$1.67M 0.04% 98
2016
Q2 		$3.45M Buy
+62,352
New +$3.43M 0.1% 86

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Axiom Investors's PBH Position: Q1 2023 in Review

Axiom Investors sold out of Prestige Consumer Healthcare (PBH) in Q1 2023, closing a stake of 18,120 shares — an estimated $1.13M sold.

Axiom Investors first reported a position in PBH in Q2 2016 and held it in 6 quarters. The position peaked at $4.89M in Q2 2022. 283 funds tracked by Wall St. Rank hold PBH as of Q1 2023.

  • Axiom Investors reported no remaining Prestige Consumer Healthcare position as of Q1 2023 after selling out during the quarter.
  • Axiom Investors sold 18,120 Prestige Consumer Healthcare shares in Q1 2023, an estimated $1.13M.
  • Axiom Investors first reported a position in Prestige Consumer Healthcare in Q2 2016 and held it in 6 quarters.
  • Axiom Investors's Prestige Consumer Healthcare position peaked at $4.89M in Q2 2022.
  • 283 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2023.

Based on Axiom Investors's 13F filing for Q1 2023, filed 12 May 2023.